7041 related articles for article (PubMed ID: 22690541)
1. [Clinical findings and prognosis of 11 cases of conjunctival malignant melanoma].
Kimura K; Usui Y; Goto H
Nippon Ganka Gakkai Zasshi; 2012 May; 116(5):503-9. PubMed ID: 22690541
[TBL] [Abstract][Full Text] [Related]
2. Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patients.
Shields CL
Trans Am Ophthalmol Soc; 2000; 98():471-92. PubMed ID: 11190037
[TBL] [Abstract][Full Text] [Related]
3. Factors affecting recurrence and metastasis in conjunctival melanoma.
Çalış Karanfil F; Gündüz AK; Gündüz ÖÖ; Özalp Ateş FS
Int Ophthalmol; 2023 Nov; 43(11):4203-4215. PubMed ID: 37639080
[TBL] [Abstract][Full Text] [Related]
4. Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: clinical experience with histopathologic observations.
Demirci H; McCormick SA; Finger PT
Arch Ophthalmol; 2000 Jul; 118(7):885-91. PubMed ID: 10900099
[TBL] [Abstract][Full Text] [Related]
5. [Malignant conjunctival melanoma. Clinical review with recommendations for diagnosis, therapy and follow-up].
Lommatzsch PK; Werschnik C
Klin Monbl Augenheilkd; 2002 Oct; 219(10):710-21. PubMed ID: 12447715
[TBL] [Abstract][Full Text] [Related]
6. Conjunctival melanoma: outcomes based on tumor origin in 382 consecutive cases.
Shields CL; Markowitz JS; Belinsky I; Schwartzstein H; George NS; Lally SE; Mashayekhi A; Shields JA
Ophthalmology; 2011 Feb; 118(2):389-95.e1-2. PubMed ID: 20723990
[TBL] [Abstract][Full Text] [Related]
7. Conjunctival melanoma: the role of conservative surgery and radiotherapy in regional metastatic disease.
Tatla T; Hungerford J; Plowman N; Ghufoor K; Keene M
Laryngoscope; 2005 May; 115(5):817-22. PubMed ID: 15867646
[TBL] [Abstract][Full Text] [Related]
8. Conjunctival melanoma in the Netherlands: a nationwide study.
Missotten GS; Keijser S; De Keizer RJ; De Wolff-Rouendaal D
Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):75-82. PubMed ID: 15623757
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic outcome of patients suffering from malignant melanomas of the conjunctiva.
Lommatzsch PK; Lommatzsch RE; Kirsch I; Fuhrmann P
Br J Ophthalmol; 1990 Oct; 74(10):615-9. PubMed ID: 2285686
[TBL] [Abstract][Full Text] [Related]
10. Management of conjunctival melanoma.
Damato B; Coupland SE
Expert Rev Anticancer Ther; 2009 Sep; 9(9):1227-39. PubMed ID: 19761427
[TBL] [Abstract][Full Text] [Related]
11. Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patients.
Shields CL; Shields JA; Gündüz K; Cater J; Mercado GV; Gross N; Lally B
Arch Ophthalmol; 2000 Nov; 118(11):1497-507. PubMed ID: 11074806
[TBL] [Abstract][Full Text] [Related]
12. Clinical follow-up of conjunctival malignant melanoma.
Choi J; Kim M; Park HS; Lee SY
Korean J Ophthalmol; 2005 Jun; 19(2):91-5. PubMed ID: 15988922
[TBL] [Abstract][Full Text] [Related]
13. Management of pigmented conjunctival lesions.
Oellers P; Karp CL
Ocul Surf; 2012 Oct; 10(4):251-63. PubMed ID: 23084146
[TBL] [Abstract][Full Text] [Related]
14. [Malignant melanoma of the conjunctiva arising from precancerous melanosis, prognosis and treatment].
Desjardins L; Shields JA
J Fr Ophtalmol; 1983; 6(5):515-20. PubMed ID: 6630890
[TBL] [Abstract][Full Text] [Related]
15. American Joint Committee on Cancer (AJCC) clinical classification predicts conjunctival melanoma outcomes.
Shields CL; Kaliki S; Al-Dahmash SA; Lally SE; Shields JA
Ophthalmic Plast Reconstr Surg; 2012; 28(5):313-23. PubMed ID: 22965011
[TBL] [Abstract][Full Text] [Related]
16. [Treatment modalities for conjunctival melanoma].
Krause L; Mladenova A; Bechrakis NE; Kreusel KM; Plath T; Moser L; Foerster M
Klin Monbl Augenheilkd; 2009 Dec; 226(12):1012-6. PubMed ID: 20108195
[TBL] [Abstract][Full Text] [Related]
17. Clinical predictive factors for development of recurrence and metastasis in conjunctival melanoma: a review of 68 cases.
De Potter P; Shields CL; Shields JA; Menduke H
Br J Ophthalmol; 1993 Oct; 77(10):624-30. PubMed ID: 8218029
[TBL] [Abstract][Full Text] [Related]
18. [Prognostic factors in malignant melanoma of the conjunctiva. An anatomo-clinical study of 56 patients].
Desjardins L; Poncet P; Levy C; Schlienger P; Asselain B; Validire P
J Fr Ophtalmol; 1999 Apr; 22(3):315-21. PubMed ID: 10337587
[TBL] [Abstract][Full Text] [Related]
19. Cryotherapy for conjunctival primary acquired melanosis and malignant melanoma. Experience with 62 cases.
Jakobiec FA; Rini FJ; Fraunfelder FT; Brownstein S
Ophthalmology; 1988 Aug; 95(8):1058-70. PubMed ID: 3231444
[TBL] [Abstract][Full Text] [Related]
20. Low-risk and high-risk histologic features in conjunctival primary acquired melanosis with atypia: Clinicopathologic analysis of 29 cases.
Sugiura M; Colby KA; Mihm MC; Zembowicz A
Am J Surg Pathol; 2007 Feb; 31(2):185-92. PubMed ID: 17255762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
